과제정보
The chemical library used in this study was kindly provided by Korea Chemical Bank (http://www.chembank.org/) of Korea Research Institute of Chemical Technology (Daejeon, Korea). This study was supported by grants from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (HI14C1324), the National Research Foundation of Korea (NRF) (2020R1A2C3007792 and 2022R1A2B5B03001199), and the "Team Science Award" of Yonsei University College of Medicine (6-2021-0194). SBK was supported by the Brain Pool Program funded by the Ministry of Science and ICT through the NRF (2019H1D3A2A01050712). HK was supported by the Global Ph.D. Fellowship Program funded by the NRF (2019H1A2A1075632).
참고문헌
- Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71, 209-249 https://doi.org/10.3322/caac.21660
- Cancer Genome Atlas Research Network (2014) Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513, 202-209 https://doi.org/10.1038/nature13480
- Chen EI, Hewel J, Krueger JS et al (2007) Adaptation of energy metabolism in breast cancer brain metastases. Cancer Res 67, 1472-1486 https://doi.org/10.1158/0008-5472.CAN-06-3137
- Cheong JH, Yang HK, Kim H et al (2018) Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis. Lancet Oncol 19, 629-638 https://doi.org/10.1016/S1470-2045(18)30108-6
- Cristescu R, Lee J, Nebozhyn M et al (2015) Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med 21, 449-456 https://doi.org/10.1038/nm.3850
- Cho J, Lee HJ, Hwang SJ et al (2020) The interplay between slow-cycling, chemoresistant cancer cells and fibroblasts creates a proinflammatory niche for tumor progression. Cancer Res 80, 2257-2272 https://doi.org/10.1158/0008-5472.can-19-0631
- Sholl LM, Hirsch FR, Hwang D et al (2020) The promises and challenges of tumor mutation burden as an immunotherapy biomarker: a perspective from the international association for the study of lung cancer pathology committee. J Thorac Oncol 15, 1409-1424 https://doi.org/10.1016/j.jtho.2020.05.019
- Lin C, Shi X, Zhao J et al (2020) Tumor mutation burden correlates with efficacy of chemotherapy/targeted therapy in advanced non-small cell lung cancer. Front Oncol 10, 480
- Lee J, Kim H, Lee JE et al (2018) Selective cytotoxicity of the NAMPT inhibitor FK866 toward gastric cancer cells with markers of the epithelial-mesenchymal transition, due to loss of NAPRT. Gastroenterology 155, 799-814 e713
- Bridges HR, Jones AJ, Pollak MN and Hirst J (2014) Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria. Biochem J 462, 475-487 https://doi.org/10.1042/BJ20140620
- Hardie DG (2013) AMPK: a target for drugs and natural products with effects on both diabetes and cancer. Diabetes 62, 2164-2172 https://doi.org/10.2337/db13-0368
- Motoshima H, Goldstein BJ, Igata M and Araki E (2006) AMPK and cell proliferation--AMPK as a therapeutic target for atherosclerosis and cancer. J Physiol 574, 63-71 https://doi.org/10.1113/jphysiol.2006.108324
- Maharjan S, Oku M, Tsuda M, Hoseki J and Sakai Y (2014) Mitochondrial impairment triggers cytosolic oxidative stress and cell death following proteasome inhibition. Sci Rep 4, 5896 https://doi.org/10.1038/srep04694
- Wheaton WW, Weinberg SE, Hamanaka RB et al (2014) Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis. eLife 3, e02242
- Andrzejewski S, Gravel SP, Pollak M and St-Pierre J (2014) Metformin directly acts on mitochondria to alter cellular bioenergetics. Cancer Metab 2, 12
- Veiga SR, Ge X, Mercer CA et al (2018) Phenformininduced mitochondrial dysfunction sensitizes hepatocellular carcinoma for dual inhibition of mTOR. Clin Cancer Res 24, 3767-3780 https://doi.org/10.1158/1078-0432.CCR-18-0177
- Molina JR, Sun Y, Protopopova M et al (2018) An inhibitor of oxidative phosphorylation exploits cancer vulnerability. Nat Med 24, 1036-1046 https://doi.org/10.1038/s41591-018-0052-4
- Min HY, Jang HJ, Park KH et al (2019) The natural compound gracillin exerts potent antitumor activity by targeting mitochondrial complex II. Cell Death Dis 10, 810
- Shi Y, Lim SK, Liang Q et al (2019) Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma. Nature 567, 341-346 https://doi.org/10.1038/s41586-019-0993-x
- Ball S, Woods HF and Alberti KG (1974) Lacticacidosis, ketoacidosis, and hyperalaninaemia in a phenformintreated diabetic patient. Br Med J 4, 699-700 https://doi.org/10.1136/bmj.4.5946.699
- Khan H, Anshu A, Prasad A et al (2019) Metabolic rewiring in response to biguanides is mediated by mROS/HIF-1a in malignant lymphocytes. Cell Rep 29, 3009-3018. e4 https://doi.org/10.1016/j.celrep.2019.11.007